Next Century Growth Investors’s Aerie Pharmaceuticals AERI Stock Holding History

Next Century Growth Investors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-152,441	Closed	-$7.24M	–	142
2019 Q1	$7.24M	Sell	152,441 -18,647	-11%	-$821K	0.97%	32
2018 Q4	$6.18M	Buy	171,088 +24,791	+17%	+$1.16M	0.88%	45
2018 Q3	$9M	Buy	+146,297	New	+$9.4M	1.04%	36
2018 Q2	–	Sell	-73,979	Closed	-$4.01M	–	154
2018 Q1	$4.01M	Sell	73,979 -18,564	-20%	-$1.04M	0.54%	62
2017 Q4	$5.53M	Sell	92,543 -8,344	-8%	-$506K	0.69%	52
2017 Q3	$4.9M	Sell	100,887 -37,197	-27%	-$2.03M	0.59%	62
2017 Q2	$7.26M	Buy	+138,084	New	+$6.43M	0.7%	55

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Next Century Growth Investors's AERI Position: Q2 2019 in Review

Next Century Growth Investors sold out of Aerie Pharmaceuticals (AERI) in Q2 2019, closing a stake of 152,441 shares — an estimated $7.24M sold.

Next Century Growth Investors first reported a position in AERI in Q2 2017 and held it in 7 quarters. The position peaked at $9M in Q3 2018. 167 funds tracked by Wall St. Rank hold AERI as of Q2 2019.

Next Century Growth Investors reported no remaining Aerie Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Next Century Growth Investors sold 152,441 Aerie Pharmaceuticals shares in Q2 2019, an estimated $7.24M.
Next Century Growth Investors first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 7 quarters.
Next Century Growth Investors's Aerie Pharmaceuticals position peaked at $9M in Q3 2018.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2019.

Based on Next Century Growth Investors's 13F filing for Q2 2019, filed 14 Aug 2019.